Charming Medical Limited (MCTA)

Charming Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023
Revenue	6.33	6.02	3.53
Revenue Growth (YoY)	-	70.37%	-
Cost of Revenue	-	0.01	0.02
Gross Profit	6.32	6	3.51
Selling, General & Admin	-	1.24	1
Other Operating Expenses	0	3.75	3.03
Operating Expenses	-	5	4.03
Operating Income	1.12	1.01	-0.52
Interest Expense / Income	-0.01	0.01	0.01
Other Expense / Income	0.01	-0	-0.11
Pretax Income	1.08	0.96	-0.39
Income Tax	0.2	0.18	-0.08
Net Income	0.91	0.82	-0.34
Net Income Common	0.87	0.78	-0.31
Free Cash Flow	0.01	0.08	1.83
Gross Margin	99.80%	99.81%	99.51%
Operating Margin	17.69%	16.77%	-14.77%
Profit Margin	13.78%	12.93%	-8.64%
Free Cash Flow Margin	0.16%	1.41%	51.76%
Effective Tax Rate	19.00%	18.94%	-
EBITDA	1.47	1.4	-0.2
EBITDA Margin	23.15%	23.30%	-5.65%
Depreciation & Amortization	0.36	0.39	0.21
EBIT	1.11	1.01	-0.41
EBIT Margin	17.50%	16.79%	-11.63%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).